After refining a protocol enabling the decitabine-mediated conversion of more than half of initially CSPG4-negative ovarian cancer cells to CSPG4-positive cells, CSPG4-directed cytokine secretion and cytotoxicity by CSPG4-specific CAR-T cells could be demonstrated [73]. The gene discussed is CSPG4; the disease is ovarian carcinoma.